Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria

Kaelin, Agnes; Casez, Jean-Paul; Jaeger, Philippe (2004). Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria. Urological research, 32(1), pp. 61-68. Springer-Verlag 10.1007/s00240-003-0386-2

[img]
Preview
Text
240_2003_Article_386.pdf - Published Version
Available under License Publisher holds Copyright.

Download (253kB) | Preview

Vitamin B6 metabolites and their potential correlates to urinary oxalate excretion in idiopathic calcium stone formers (ICSF) compared with healthy subjects were investigated. This clinical study was performed in a population of male ICSF with (Hyperoxalurics, n=55) or without hyperoxaluria (Normooxalurics, n=57) as well as in 100 healthy male control subjects. Pyridoxal 5’-phosphate serum concentration (S-pyridoxal 5’P) and 24-h urinary excretion of 4-pyridoxic acid (U-4pyridoxic acid) were measured using HPLC; 24-h urinary excretion of oxalate (U-oxalate) was measured concurrently. A subgroup of subjects (40 Hyperoxalurics, 15 Normooxalurics and 50 controls) underwent the same measurements before and after 7-day pyridoxine loading per os (pyridoxine hydrochloride, 300 mg/d). Under usual conditions, U-4pyridoxic acid was similar in the three groups, whereas mean S-pyridoxal 5’P was significantly lower (p<0.0001) in the Hyperoxalurics (59.6±21.2 nmol/L) and in the Normooxalurics (64.9±19.7 nmol/L) than in the controls (86.0±31.0 nmol/L). No correlation could be found between U-oxalate and U-4pyridoxic acid or S-pyridoxal 5’P. After B6 loading, S-pyridoxal 5’P was still significantly lower in the Hyperoxalurics (415±180 nmol/L, p<0.001) and in the Normooxalurics (429±115 nmol/L, p=0.036) than in the controls (546±180 nmol/L), although there was no difference between groups for U-4pyridoxic acid. No correlation in any group could be found between changes in U-oxalate and changes in U-4pyridoxic acid or S-pyridoxal 5’P. Although there is no vitamin B6 deficiency in ICSF with or without hyperoxaluria, these patients, on average, have lower levels of S-pyridoxal 5’P than healthy subjects. However, this slight decrease does not seem to account for idiopathic hyperoxaluria.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension

ISSN:

0300-5623

Publisher:

Springer-Verlag

Language:

English

Submitter:

Marceline Brodmann

Date Deposited:

30 Sep 2020 13:45

Last Modified:

09 May 2024 18:38

Publisher DOI:

10.1007/s00240-003-0386-2

BORIS DOI:

10.7892/boris.117943

URI:

https://boris.unibe.ch/id/eprint/117943

Actions (login required)

Edit item Edit item
Provide Feedback